Targeting of the Hydrophobic Metabolome by Pathogens

Traffic

Volumn 16, Issue 5, 2015, Pages 439-460

  Helms, J Bernd ^a   Kaloyanova, Dora V ^a   Strating, Jeroen R P ^b   van Hellemond, Jaap J ^c   van der Schaar, Hilde M ^b   Tielens, Aloysius G M ^a,c   van Kuppeveld, Frank J M ^b   Brouwers, Jos F ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bacteria; Fungi; Host pathogen interactions; Lipidome; Lipids; Metabolome; Parasites; Viruses

Indexed keywords

ICOSANOID; LIPID; LIPIDOME; POLYUNSATURATED FATTY ACID;

HOST CELL; HOST PATHOGEN INTERACTION; HYDROPHOBICITY; IMMUNE SYSTEM; INFLAMMATION; METABOLOME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; BACTERIAL PHENOMENA AND FUNCTIONS; CHEMICAL PHENOMENA; COMMUNICABLE DISEASE; FUNGUS; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LIPID METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY;

BACTERIAL PHYSIOLOGICAL PHENOMENA; COMMUNICABLE DISEASES; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNITY, INNATE; LIPID METABOLISM; METABOLOME; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84928177777     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12280     Document Type: Review

References (247)

1. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics - the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012;13:263-269.
2. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, et al. HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res 2013;41:D801-D807.
3. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. METLIN: a metabolite mass spectral database. Ther Drug Monit 2005;27:747-751.
4. Tautenhahn R, Cho K, Uritboonthai W, Zhu Z, Patti GJ, Siuzdak G. An accelerated workflow for untargeted metabolomics using the METLIN database. Nat Biotechnol 2012;30:826-828.
5. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
6. Griffiths WJ, Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009;38:1882-1896.
7. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005;4:594-610.
8. Van Meer G. Cellular lipidomics. EMBO J 2005;24:3159-3165.
9. Dennis EA. Lipidomics joins the omics evolution. Proc Natl Acad Sci USA 2009;106:2089-2090.
10. Wenk MR. Lipidomics: new tools and applications. Cell 2010;143:888-895.
11. Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol 2010;11:593-598.
12. Harkewicz R, Dennis EA. Applications of mass spectrometry to lipids and membranes. Annu Rev Biochem 2011;80:301-325.
13. Brouwers JF. Liquid chromatographic-mass spectrometric analysis of phospholipids: chromatography, ionization and quantification. Biochim Biophys Acta 2011;1811:763-775.
14. Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 2012;31:134-178.
15. Brügger B. Lipidomics: analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry. Annu Rev Biochem 2014;83:79-98.
16. Fahy E, Sud M, Cotter D, Subramaniam S. LIPID MAPS online tools for lipid research. Nucleic Acids Res 2007;35:W606-W612.
17. Sud M, Fahy E, Cotter D, Brown A, Dennis EA, Glass CK, Merrill AH, Murphy RC, Raetz CRH, Russell DW, Subramaniam S. LMSD: LIPID MAPS structure database. Nucleic Acids Res 2007;35:D527-D532.
18. Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M. Informatics and computational strategies for the study of lipids. Mol Biosyst 2008;4:121-127.
19. Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH, Murphy RC, Raetz CRH, Russell DW, Seyama Y, Shaw W, Shimizu T, Spener F, van Meer G, VanNieuwenhze MS, White SH, et al. A comprehensive classification system for lipids. J Lipid Res 2005;46:839-861.
20. Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CRH, Shimizu T, Spener F, van Meer G, Wakelam MJO, Dennis EA. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009;50(Suppl):S9-S14.
21. Higdon A, Diers AR, Oh JY, Landar A, Darley-Usmar VM. Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J 2012;442:453-464.
22. Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem 2010;79:803-833.
23. Ham H, Sreelatha A, Orth K. Manipulation of host membranes by bacterial effectors. Nat Rev Microbiol 2011;9:635-646.
24. Hilbi H, Haas A. Secretive bacterial pathogens and the secretory pathway. Traffic 2012;13:1187-1197.
25. Guichard A, Nizet V, Bier E. RAB11-mediated trafficking in host-pathogen interactions. Nat Rev Microbiol 2014;12:624-634.
26. Heung LJ, Luberto C, Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect Immun 2006;74:28-39.
27. Wenk MR. Lipidomics of host-pathogen interactions. FEBS Lett 2006;580:5541-5551.
28. Van der Meer-Janssen YPM, van Galen J, Batenburg JJ, Helms JB. Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 2010;49:1-26.
29. Chukkapalli V, Heaton NS, Randall G. Lipids at the interface of virus-host interactions. Curr Opin Microbiol 2012;15:512-518.
30. Vromman F, Subtil A. Exploitation of host lipids by bacteria. Curr Opin Microbiol 2014;17:38-45.
31. Sviridov D, Bukrinsky M. Interaction of pathogens with host cholesterol metabolism. Curr Opin Lipidol 2014;25:333-338.
32. Haneburger I, Hilbi H. Phosphoinositide lipids and the Legionella pathogen vacuole. Curr Top Microbiol Immunol 2013;376:155-173.
33. Elwell CA, Engel JN. Lipid acquisition by intracellular Chlamydiae. Cell Microbiol 2012;14:1010-1018.
34. Van der Goot FG, Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 2001;13:89-97.
35. Mañes S, del Real G, Martínez-A C. Pathogens: raft hijackers. Nat Rev Immunol 2003;3:557-568.
36. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010;11:688-699.
37. Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJM, Altan-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010;141:799-811.
38. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci USA 2009;106:7577-7582.
39. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009;5:298-307.
40. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet M-S, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, et al. Recruitment and activation of a lipid kinase by Hepatitis C Virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011;9:32-45.
41. Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, Bethell RC, Cordingley MG, Kukolj G. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 2009;387:5-10.
42. Trotard M, Lepere-Douard C, Regeard M, Piquet-Pellorce C, Lavillette D, Cosset FL, Gripon P, Le Seyec J. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J 2009;23:3780-3789.
43. Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, et al. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol 2009;83:10058-10074.
44. Reiss S, Harak C, Romero-Brey I, Radujkovic D, Klein R, Ruggieri A, Rebhan I, Bartenschlager R, Lohmann V. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of Hepatitis C virus NS5A. PLoS Pathog 2013;9:e1003359.
45. Sasaki J, Ishikawa K, Arita M, Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J 2012;31:754-766.
46. Mercer J, Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008;320:531-535.
47. Vanlandschoot P, Leroux-Roels G. Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus? Trends Immunol 2003;24:144-147.
48. Callahan MK, Popernack PM, Tsutsui S, Truong L, Schlegel RA, Henderson AJ. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J Immunol 2003;170:4840-4845.
49. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006;80:10109-10116.
50. Coil DA, Miller AD. Enhancement of enveloped virus entry by phosphatidylserine. J Virol 2005;79:11496-11500.
51. Rothwell C, Lebreton A, Young Ng C, Lim JY, Liu W, Vasudevan S, Labow M, Gu F, Gaither LA. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 2009;389:8-19.
52. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 1999;274:2038-2044.
53. Aizaki H, Lee K-J, Sung VM-H, Ishiko H, Lai MMC. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 2004;324:450-461.
54. Amako Y, Sarkeshik A, Hotta H, Yates J, Siddiqui A. Role of oxysterol binding protein in hepatitis C virus infection. J Virol 2009;83:9237-9246.
55. Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol 2013;87:10612-10627.
56. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001;17:1009-1019.
57. Zheng Y-H, Plemenitas A, Fielding CJ, Peterlin BM. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci USA 2003;100:8460-8465.
58. Chang KO. Role of cholesterol pathways in norovirus replication. J Virol 2009;83:8587-8595.
59. Martín-Acebes MA, Blázquez A-B, Jiménez de Oya N, Escribano-Romero E, Saiz J-C. West Nile Virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One 2011;6:e24970.
60. Wang H, Perry JW, Lauring AS, Neddermann P, De Francesco R, Tai AW. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology 2014;146:1373-1385.
61. Ilnytska O, Santiana M, Hsu N-Y, Du W-L, Chen Y-H, Viktorova EG, Belov G, Brinker A, Storch J, Moore C, Dixon JL, Altan-Bonnet N. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 2013;14:281-293.
62. Roulin PS, Lötzerich M, Torta F, Tanner LB, van Kuppeveld FJM, Wenk MR, Greber UF. A phosphatidylinositol 4-phosphate and cholesterol counter-current model for the formation of rhinovirus replication compartments at ER-Golgi interface. Cell Host Microbe 2014;16:677-690.
63. Arita M. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol Immunol 2014;58:239-256.
64. Nchoutmboube JA, Viktorova EG, Scott AJ, Ford LA, Pei Z, Watkins PA, Ernst RK, Belov GA. Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog 2013;9:e1003401.
65. Perera R, Riley C, Isaac G, Hopf-Jannasch AS, Moore RJ, Weitz KW, Pasa-Tolic L, Metz TO, Adamec J, Kuhn RJ. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog 2012;8:e1002584.
66. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci USA 2010;107:17345-17350.
67. Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 2005;102:2561-2566.
68. Moser TS, Schieffer D, Cherry S. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog 2012;8:e1002661.
69. Greseth MD, Traktman P. De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog 2014;10:e1004021.
70. Yang W, Hood BL, Chadwick SL, Liu S, Watkins SC, Luo G, Conrads TP, Wang T. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 2008;48:1396-1403.
71. Pizarro-Cerdá J, Cossart P. Subversion of phosphoinositide metabolism by intracellular bacterial pathogens. Nat Cell Biol 2004;6:1026-1033.
72. Drecktrah D, Knodler LA, Steele-Mortimer O. Modulation and utilization of host cell phosphoinositides by Salmonella spp. Infect Immun 2004;72:4331-4335.
73. Wong K-W, Isberg RR. Arf6 and phosphoinositol-4-phosphate-5-kinase activities permit bypass of the Rac1 requirement for beta1 integrin-mediated bacterial uptake. J Exp Med 2003;198:603-614.
74. Hilbi H. Modulation of phosphoinositide metabolism by pathogenic bacteria. Cell Microbiol 2006;8:1697-1706.
75. Krauss M, Haucke V. Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO Rep 2007;8:241-246.
76. Bakowski MA, Braun V, Lam GY, Yeung T, Heo WD, Meyer T, Finlay BB, Grinstein S, Brumell JH. The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole. Cell Host Microbe 2010;7:453-462.
77. Harding CR, Mattheis C, Mousnier A, Oates CV, Hartland EL, Frankel G, Schroeder GN. LtpD is a novel Legionella pneumophila effector that binds phosphatidylinositol 3-phosphate and inositol monophosphatase IMPA1. Infect Immun 2013;81:4261-4270.
78. Pizarro-Cerdá J, Kühbacher A, Cossart P. Phosphoinositides and host-pathogen interactions. Biochim Biophys Acta 2014 (In press).
79. Lafont F, Tran Van Nhieu G, Hanada K, Sansonetti P, van der Goot FG. Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J 2002;21:4449-4457.
80. Carabeo RA, Mead DJ, Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci USA 2003;100:6771-6776.
81. Catron DM, Sylvester MD, Lange Y, Kadekoppala M, Jones BD, Monack DM, Falkow S, Haldar K. The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell Microbiol 2002;4:315-328.
82. De Chastellier C, Thilo L. Cholesterol depletion in Mycobacterium avium-infected macrophages overcomes the block in phagosome maturation and leads to the reversible sequestration of viable mycobacteria in phagolysosome-derived autophagic vacuoles. Cell Microbiol 2006;8:242-256.
83. Gilk SD, Cockrell DC, Luterbach C, Hansen B, Knodler LA, Ibarra JA, Steele-Mortimer O, Heinzen RA. Bacterial colonization of host cells in the absence of cholesterol. PLoS Pathog 2013;9:e1003107.
84. Gupta VR, Patel HK, Kostolansky SS, Ballivian RA, Eichberg J, Blanke SR. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog 2008;4:e1000073.
85. Hanada K. Sphingolipids in infectious diseases. Jpn J Infect Dis 2005;58:131-148.
86. Moore ER, Fischer ER, Mead DJ, Hackstadt T. The chlamydial inclusion preferentially intercepts basolaterally directed sphingomyelin-containing exocytic vacuoles. Traffic 2008;9:2130-2140.
87. Arena ET, Auweter SD, Antunes LCM, Vogl AW, Han J, Guttman JA, Croxen MA, Menendez A, Covey SD, Borchers CH, Finlay BB. The deubiquitinase activity of the Salmonella pathogenicity island 2 effector, SseL, prevents accumulation of cellular lipid droplets. Infect Immun 2011;79:4392-4400.
88. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 2011;7:e1002093.
89. Kumar Y, Cocchiaro J, Valdivia RH. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 2006;16:1646-1651.
90. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci USA 2008;105:9379-9384.
91. Dowhan W, Mileykovskaya E, Bogdanov M. Diversity and versatility of lipid|-protein interactions revealed by molecular genetic approaches. Biochim Biophys Acta 2004;1666:19-39.
92. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000;13:122-143.
93. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001;39:166-175.
94. Rhome R, Del Poeta M. Sphingolipid signaling in fungal pathogens. Adv Exp Med Biol 2010;688:232-237.
95. Rheeder JP, Marasas WFO, Vismer HF. Production of fumonisin analogs by Fusarium species. Appl Environ Microbiol 2002;68:2101-2105.
96. Merrill AH, Wang E, Gilchrist DG, Riley RT. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res 1993;26:215-234.
97. Kupfahl C, Tsikas D, Niemann J, Geginat G, Hof H. Production of prostaglandins, isoprostanes and thromboxane by Aspergillus fumigatus: identification by gas chromatography-tandem mass spectrometry and quantification by enzyme immunoassay. Mol Immunol 2012;49:621-627.
98. Noverr MC, Phare SM, Toews GB, Coffey MJ, Huffnagle GB. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 2001;69:2957-2963.
99. Tsitsigiannis DI, Bok J-W, Andes D, Nielsen KF, Frisvad JC, Keller NP. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infect Immun 2005;73:4548-4559.
100. Vial HJ, Eldin P, Tielens AGM, van Hellemond JJ. Phospholipids in parasitic protozoa. Mol Biochem Parasitol 2003;126:143-154.
101. Van Hellemond JJ, Retra K, Brouwers JFHM, van Balkom BWM, Yazdanbakhsh M, Shoemaker CB, Tielens AGM. Functions of the tegument of schistosomes: clues from the proteome and lipidome. Int J Parasitol 2006;36:691-699.
102. Coppens I. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol 2013;11:823-835.
103. Ramakrishnan S, Serricchio M, Striepen B, Bütikofer P. Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans. Prog Lipid Res 2013;52:488-512.
104. Brouwers JF, Versluis C, van Golde LMG, Tielens AGM. 5-Octadecenoic acid: evidence for a novel type of fatty acid modification in schistosomes. Biochem J 1998;334:315-319.
105. Bomsel M, Alfsen A. Entry of viruses through the epithelial barrier: pathogenic trickery. Nat Rev Mol Cell Biol 2003;4:57-68.
106. Smith AE, Helenius A. How viruses enter animal cells. Science 2004;304:237-242.
107. Mazzon M, Mercer J. Lipid interactions during virus entry and infection. Cell Microbiol 2014;16:1493-1502.
108. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell 2005;97:147-172.
109. Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol 2008;6:363-374.
110. Romero-Brey I, Bartenschlager R. Membranous replication factories induced by plus-strand RNA viruses. Viruses 2014;6:2826-2857.
111. Den Boon JA, Diaz A, Ahlquist P. Cytoplasmic viral replication complexes. Cell Host Microbe 2010;8:77-85.
112. Mankouri J, Tedbury PR, Gretton S, Hughes ME, Griffin SD, Dallas ML, Green KA, Hardie DG, Peers C, Harris M. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proc Natl Acad Sci USA 2010;107:11549-11554.
113. Lyn RK, Singaravelu R, Kargman S, O'Hara S, Chan H, Oballa R, Huang Z, Jones DM, Ridsdale A, Russell RS, Partridge AW, Pezacki JP. Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci Rep 2014;4:4549.
114. Tai AW, Salloum S. The role of the phosphatidylinositol 4-kinase PI4KA in hepatitis C virus-induced host membrane rearrangement. PLoS One 2011;6:e26300.
115. Zhang L, Hong Z, Lin W, Shao R-X, Goto K, Hsu VW, Chung RT. ARF1 and GBF1 generate a PI4P-enriched environment supportive of Hepatitis C virus replication. PLoS One 2012;7:e32135.
116. Van der Schaar HM, Leyssen P, Thibaut HJ, de Palma A, van der Linden L, Lanke KH, Lacroix C, Verbeken E, Conrath K, Macleod AM, Mitchell DR, Palmer NJ, van de Poel H, Andrews M, Neyts J, et al. A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta. Antimicrob Agents Chemother 2013;57:4971-4981.
117. Spickler C, Lippens J, Laberge MK, Desmeules S, Bellavance E, Garneau M, Guo T, Hucke O, Leyssen P, Neyts J, Vaillancourt FH, Decor A, O'Meara J, Franti M, Gauthier A. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Antimicrob Agents Chemother 2013;57:3358-3368.
118. Baird NL, York J, Nunberg JH. Arenavirus infection induces discrete cytosolic structures for RNA replication. J Virol 2012;86:11301-11310.
119. Tanner LB, Chng C, Guan XL, Lei Z, Rozen SG, Wenk MR. Lipidomics identifies a requirement for peroxisomal function during influenza virus replication. J Lipid Res 2014;55:1357-1365.
120. Hirata Y, Ikeda K, Sudoh M, Tokunaga Y, Suzuki A, Weng L, Ohta M, Tobita Y, Okano K, Ozeki K, Kawasaki K, Tsukuda T, Katsume A, Aoki Y, Umehara T, et al. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog 2012;8:e1002860.
121. Mesmin B, Bigay J, Moser von Filseck J, Lacas-Gervais S, Drin G, Antonny B. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 2013;155:830-843.
122. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007;81:8122-8130.
123. Rodgers MA, Saghatelian A, Yang PL. Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profiling. J Am Chem Soc 2009;131:5030-5031.
124. Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PL. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for Hepatitis C Virus. J Am Chem Soc 2012;134:6896-6899.
125. Lorizate M, Kräusslich H-G. Role of lipids in virus replication. Cold Spring Harb Perspect Biol 2011;3:a004820.
126. Brügger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Kräusslich HG. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci USA 2006;103:2641-2646.
127. Brügger B, Krautkramer E, Tibroni N, Munte CE, Rauch S, Leibrecht I, Glass B, Breuer S, Geyer M, Krausslich HG, Kalbitzer HR, Wieland FT, Fackler OT. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 2007;4:70.
128. Martin-Acebes MA, Merino-Ramos T, Blazquez AB, Casas J, Escribano-Romero E, Sobrino F, Saiz JC. The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism on flavivirus biogenesis. J Virol 2014;88:12041-12054.
129. Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, Smith JK, Pernet O, Guo H, Nusbaum R, Zack JA, Freiberg AN, Su L, Lee B, Cheng G. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 2013;38:92-105.
130. Blanc M, Hsieh WY, Robertson KA, Kropp KA, Forster T, Shui G, Lacaze P, Watterson S, Griffiths SJ, Spann NJ, Meljon A, Talbot S, Krishnan K, Covey DF, Wenk MR, et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 2013;38:106-118.
131. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, Jung JU. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013;13:452-464.
132. Mackenzie JM, Khromykh AA, Parton RG. Cholesterol manipulation by West Nile Virus perturbs the cellular immune response. Cell Host Microbe 2007;2:229-239.
133. Stein M-P, Müller MP, Wandinger-Ness A. Bacterial pathogens commandeer Rab GTPases to establish intracellular niches. Traffic 2012;13:1565-1588.
134. Ehrt S, Rhee K. Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes. Curr Top Microbiol Immunol 2013;374:163-188.
135. Beisel WR. Metabolic response to infection. Annu Rev Med 1975;26:9-20.
136. Gillmaier N, Götz A, Schulz A, Eisenreich W, Goebel W. Metabolic responses of primary and transformed cells to intracellular Listeria monocytogenes. PLoS One 2012;7:e52378.
137. Cui J, Shao F. Biochemistry and cell signaling taught by bacterial effectors. Trends Biochem Sci 2011;36:532-540.
138. Waterman SR, Holden DW. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 2003;5:501-511.
139. Bonazzi M, Cossart P. Bacterial entry into cells: a role for the endocytic machinery. FEBS Lett 2006;580:2962-2967.
140. Humphries AC, Way M. The non-canonical roles of clathrin and actin in pathogen internalization, egress and spread. Nat Rev Microbiol 2013;11:551-560.
141. Patel JC, Galán JE. Manipulation of the host actin cytoskeleton by Salmonella - all in the name of entry. Curr Opin Microbiol 2005;8:10-15.
142. Rosenberger CM, Brumell JH, Finlay BB. Microbial pathogenesis: lipid rafts as pathogen portals. Curr Biol 2000;10:R823-R825.
143. LaRock DL, Brzovic PS, Levin I, Blanc M-P, Miller SI. A Salmonella typhimurium-translocated glycerophospholipid:cholesterol acyltransferase promotes virulence by binding to the RhoA protein switch regions. J Biol Chem 2012;287:29654-29663.
144. Misselwitz B, Dilling S, Vonaesch P, Sacher R, Snijder B, Schlumberger M, Rout S, Stark M, von Mering C, Pelkmans L, Hardt W-D. RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42. Mol Syst Biol 2011;7:474.
145. Huang F-C. The critical role of membrane cholesterol in salmonella-induced autophagy in intestinal epithelial cells. Int J Mol Sci 2014;15:12558-12572.
146. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zähringer U, Mollenkopf H-J, Heinz E, Meyer TF. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006;12:1030-1038.
147. Harris JR, Bhakdi S, Meissner U, Scheffler D, Bittman R, Li G, Zitzer A, Palmer M. Interaction of the Vibrio cholerae cytolysin (VCC) with cholesterol, some cholesterol esters, and cholesterol derivatives: a TEM study. J Struct Biol 2002;139:122-135.
148. Zitzer A, Bittman R, Verbicky CA, Erukulla RK, Bhakdi S, Weis S, Valeva A, Palmer M. Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin. J Biol Chem 2001;276:14628-14633.
149. Seveau S, Bierne H, Giroux S, Prévost M-C, Cossart P. Role of lipid rafts in E-cadherin- and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J Cell Biol 2004;166:743-753.
150. Weber SS, Ragaz C, Hilbi H. Pathogen trafficking pathways and host phosphoinositide metabolism. Mol Microbiol 2009;71:1341-1352.
151. Behnia R, Munro S. Organelle identity and the signposts for membrane traffic. Nature 2005;438:597-604.
152. Mallo GV, Espina M, Smith AC, Terebiznik MR, Alemán A, Finlay BB, Rameh LE, Grinstein S, Brumell JH. SopB promotes phosphatidylinositol 3-phosphate formation on Salmonella vacuoles by recruiting Rab5 and Vps34. J Cell Biol 2008;182:741-752.
153. Roppenser B, Grinstein S, Brumell JH. Modulation of host phosphoinositide metabolism during Salmonella invasion by the type III secreted effector SopB. Methods Cell Biol 2012;108:173-186.
154. Cambier CJ, Takaki KK, Larson RP, Hernandez RE, Tobin DM, Urdahl KB, Cosma CL, Ramakrishnan L. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 2014;505:218-222.
155. Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B. Conversion of PtdIns(4, 5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J 2002;21:5069-5078.
156. Alonso A, García-del Portillo F. Hijacking of eukaryotic functions by intracellular bacterial pathogens. Int Microbiol 2004;7:181-191.
157. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006;443:651-657.
158. De Matteis MA, Di Campli A, Godi A. The role of the phosphoinositides at the Golgi complex. Biochim Biophys Acta 2005;1744:396-405.
159. Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H. Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog 2006;2:e46.
160. Dukes JD, Lee H, Hagen R, Reaves BJ, Layton AN, Galyov EE, Whitley P. The secreted Salmonella dublin phosphoinositide phosphatase, SopB, localizes to PtdIns(3)P-containing endosomes and perturbs normal endosome to lysosome trafficking. Biochem J 2006;395:239-247.
161. Terebiznik MR, Vieira OV, Marcus SL, Slade A, Yip CM, Trimble WS, Meyer T, Finlay BB, Grinstein S. Elimination of host cell PtdIns(4, 5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol 2002;4:766-773.
162. Hernandez LD, Hueffer K, Wenk MR, Galán JE. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 2004;304:1805-1807.
163. Pendaries C, Tronchère H, Arbibe L, Mounier J, Gozani O, Cantley L, Fry MJ, Gaits-Iacovoni F, Sansonetti PJ, Payrastre B. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J 2006;25:1024-1034.
164. Vergne I, Chua J, Lee H-H, Lucas M, Belisle J, Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2005;102:4033-4038.
165. Howe D, Heinzen RA. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell Microbiol 2006;8:496-507.
166. Gilk SD. Role of lipids in Coxiella burnetii infection. Adv Exp Med Biol 2012;984:199-213.
167. Garner MJ, Hayward RD, Koronakis V. The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking. Cell Microbiol 2002;4:153-165.
168. Kuhle V, Abrahams GL, Hensel M. Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner. Traffic 2006;7:716-730.
169. Haas A. The phagosome: compartment with a license to kill. Traffic 2007;8:311-330.
170. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA 2008;105:4376-4380.
171. Ploegh HL. A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature 2007;448:435-438.
172. Goodman JM. The gregarious lipid droplet. J Biol Chem 2008;283:28005-28009.
173. Nawabi P, Catron DM, Haldar K. Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection. Mol Microbiol 2008;68:173-185.
174. Stehr M, Elamin AA, Singh M. Cytosolic lipid inclusions formed during infection by viral and bacterial pathogens. Microbes Infect 2012;14:1227-1237.
175. Luo M, Fadeev EA, Groves JT. Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol 2005;1:149-153.
176. Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 1843;2014:2563-2582.
177. Barbosa T, Rescigno M. Host-bacteria interactions in the intestine: homeostasis to chronic inflammation. Wiley Interdiscip Rev Syst Biol Med 2010;2:80-97.
178. Tam VC. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections. Semin Immunol 2013;25:240-248.
179. Agard M, Asakrah S, Morici LA. PGE(2) suppression of innate immunity during mucosal bacterial infection. Front Cell Infect Microbiol 2013;3:45.
180. Uchiya K, Groisman EA, Nikai T. Involvement of Salmonella pathogenicity island 2 in the up-regulation of interleukin-10 expression in macrophages: role of protein kinase A signal pathway. Infect Immun 2004;72:1964-1973.
181. Vance RE, Hong S, Gronert K, Serhan CN, Mekalanos JJ. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci USA 2004;101:2135-2139.
182. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-361.
183. Hawksworth DL. The magnitude of fungal diversity: the 1.5 million species estimate revisited. Mycol Res 2001;105:1422-1432.
184. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 2001;356:983-989.
185. Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014;14:405-416.
186. Plano D, Amin S, Sharma AK. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. J Med Chem 2014;57:5509-5524.
187. Merrill AH. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 2002;277:25843-25846.
188. Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G. Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 2006;1758:1957-1977.
189. Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 2003;1632:16-30.
190. Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf H-U, Liotta DC, Peng Q, Merrill AH. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta 2002;1585:188-192.
191. Abbas HK, Paul RN, Riley RT, Tanaka T, Shier WT. Ultrastructural effects of AAL-toxin TA from the fungus Alternaria alternata on black nightshade (Solanum nigrum L.) leaf discs and correlation with biochemical measures of toxicity. Toxicon 1998;36:1821-1832.
192. Mandala SM, Harris GH. Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungins, rustmicin, and khafrefungin. Methods Enzymol 2000;311:335-348.
193. Heidler SA, Radding JA. Inositol phosphoryl transferases from human pathogenic fungi. Biochim Biophys Acta 2000;1500:147-152.
194. Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH, Hennig M, Luberto C, Del Poeta M. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J Clin Invest 2006;116:1651-1659.
195. Buczynski MW, Dumlao DS, Dennis EA. Thematic review series: proteomics - an integrated omics analysis of eicosanoid biology. J Lipid Res 2009;50:1015-1038.
196. Galano J-M, Mas E, Barden A, Mori TA, Signorini C, De Felice C, Barrett A, Opere C, Pinot E, Schwedhelm E, Benndorf R, Roy J, Le Guennec J-Y, Oger C, Durand T. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins Other Lipid Mediat 2013;107:95-102.
197. Andreou A, Brodhun F, Feussner I. Biosynthesis of oxylipins in non-mammals. Prog Lipid Res 2009;48:148-170.
198. Pohl CH, Kock JLF. Oxidized fatty acids as inter-kingdom signaling molecules. Molecules 2014;19:1273-1285.
199. Scher JU, Pillinger MH. The anti-inflammatory effects of prostaglandins. J Investig Med 2009;57:703-708.
200. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 2008;43:831-841.
201. Kalo-Klein A, Witkin SS. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun 1990;58:260-262.
202. Alem MAS, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 2005;54:1001-1005.
203. Brouwers JF, Smeenk IM, van Golde LMG, Tielens AGM. The incorporation, modification and turnover of fatty acids in adult Schistosoma mansoni. Mol Biochem Parasitol 1997;88:175-185.
204. Coppens I. Contribution of host lipids to Toxoplasma pathogenesis. Cell Microbiol 2006;8:1-9.
205. Van Hellemond JJ, Tielens AGM. Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei. FEBS Lett 2006;580:5552-5558.
206. Mazumdar J, Striepen B. Make it or take it: fatty acid metabolism of apicomplexan parasites. Eukaryot Cell 2007;6:1727-1735.
207. Rub A, Arish M, Husain SA, Ahmed N, Akhter Y. Host-lipidome as a potential target of protozoan parasites. Microbes Infect 2013;15:649-660.
208. Smith TM, Brooks TJ. Lipid fractions in adult Schistosoma mansoni. Parasitology 1969;59:293-298.
209. Meyer F, Meyer H, Bueding E. Lipid metabolism in the parasitic and free-living flatworms, Schistosoma mansoni and Dugesia dorotocephala. Biochim Biophys Acta 1970;210:257-266.
210. Brouwers JF, Gadella BM, van Golde LMG, Tielens AGM. Quantitative analysis of phosphatidylcholine molecular species using HPLC and light scattering detection. J Lipid Res 1998;39:344-353.
211. Kubata BK, Duszenko M, Martin KS, Urade Y. Molecular basis for prostaglandin production in hosts and parasites. Trends Parasitol 2007;23:325-331.
212. Belley A, Chadee K. Eicosanoid production by parasites: from pathogenesis to immunomodulation? Parasitol Today 1995;11:327-334.
213. Da'dara A, Skelly PJ. Manipulation of vascular function by blood flukes? Blood Rev 2011;25:175-179.
214. Palacpac NMQ, Hiramine Y, Seto S, Hiramatsu R, Horii T, Mitamura T. Evidence that Plasmodium falciparum diacylglycerol acyltransferase is essential for intraerythrocytic proliferation. Biochem Biophys Res Commun 2004;321:1062-1068.
215. Palacpac NMQ, Hiramine Y, Mi-ichi F, Torii M, Kita K, Hiramatsu R, Horii T, Mitamura T. Developmental-stage-specific triacylglycerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium falciparum-infected erythrocytes. J Cell Sci 2004;117:1469-1480.
216. Majumder S, Dey R, Bhattacharjee S, Rub A, Gupta G, Bhattacharyya Majumdar S, Saha B, Majumdar S. Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite. J Infect Dis 2012;205:1607-1616.
217. Zhang K, Hsu F-F, Scott DA, Docampo R, Turk J, Beverley SM. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol Microbiol 2005;55:1566-1578.
218. Romano JD, Sonda S, Bergbower E, Smith ME, Coppens I. Toxoplasma gondii salvages sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole. Mol Biol Cell 2013;24:1974-1995.
219. Coppens I, Sinai AP, Joiner KA. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol 2000;149:167-180.
220. Sehgal A, Bettiol S, Pypaert M, Wenk MR, Kaasch A, Blader IJ, Joiner KA, Coppens I. Peculiarities of host cholesterol transport to the unique intracellular vacuole containing Toxoplasma. Traffic 2005;6:1125-1141.
221. Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, Tint GS, Vanier MT, Walkley SU, Lobel P. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci USA 2004;101:5886-5891.
222. Blader IJ, Manger ID, Boothroyd JC. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J Biol Chem 2001;276:24223-24231.
223. Coppens I, Joiner KA. Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol Biol Cell 2003;14:3804-3820.
224. Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A. Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol 2004;133:145-152.
225. Tewary P, Veena K, Pucadyil TJ, Chattopadhyay A, Madhubala R. The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages. Biochem Biophys Res Commun 2006;339:661-666.
226. Fernandes MC, Cortez M, Geraldo Yoneyama KA, Straus AH, Yoshida N, Mortara RA. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Int J Parasitol 2007;37:1431-1441.
227. Sandvig K, Skotland T, van Deurs B, Klokk TI. Retrograde transport of protein toxins through the Golgi apparatus. Histochem Cell Biol 2013;140:317-326.
228. Sandvig K, van Deurs B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther 2005;12:865-872.
229. Sandvig K, Bergan J, Kavaliauskiene S, Skotland T. Lipid requirements for entry of protein toxins into cells. Prog Lipid Res 2014;54:1-13.
230. De Matteis MA, Godi A. PI-loting membrane traffic. Nat Cell Biol 2004;6:487-492.
231. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins--novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988;54:1806-1811.
232. Breslow DK, Collins SR, Bodenmiller B, Aebersold R, Simons K, Shevchenko A, Ejsing CS, Weissman JS. Orm family proteins mediate sphingolipid homeostasis. Nature 2010;463:1048-1053.
233. Spiegel S, Merrill AH. Sphingolipid metabolism and cell growth regulation. FASEB J 1996;10:1388-1397.
234. Marsh M, Bolzau E, Helenius A. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 1983;32:931-940.
235. Helenius A, Mellman I, Wall D, Hubbard A. Endosomes. Trends Biochem Sci 1983;8:245-250.
236. Helenius A, Kartenbeck J, Simons K, Fries E. On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol 1980;84:404-420.
237. Pelkmans L, Helenius A. Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol 2003;15:414-422.
238. Lopes da Silva M, Thieleke-Matos C, Cabrita-Santos L, Ramalho JS, Wavre-Shapton ST, Futter CE, Barral DC, Seabra MC. The host endocytic pathway is essential for Plasmodium berghei late liver stage development. Traffic 2012;13:1351-1363.
239. Bano N, Romano JD, Jayabalasingham B, Coppens I. Cellular interactions of Plasmodium liver stage with its host mammalian cell. Int J Parasitol 2007;37:1329-1341.
240. King CA, Van Heyningen WE. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J Infect Dis 1973;127:639-647.
241. Contreras F-X, Ernst AM, Haberkant P, Björkholm P, Lindahl E, Gönen B, Tischer C, Elofsson A, von Heijne G, Thiele C, Pepperkok R, Wieland F, Brügger B. Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 2012;481:525-529.
242. Olkkonen VM, Li S. Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog Lipid Res 2013;52:529-538.
243. Raetz CRH, Reynolds CM, Trent MS, Bishop RE. Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 2007;76:295-329.
244. Van der Kleij D, Latz E, Brouwers JFHM, Kruize YCM, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT, Tielens AGM, Yazdanbakhsh M. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002;277:48122-48129.
245. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004;32:D277-D280.
246. Bates JT, Chivian D, Arkin AP. GLAMM: genome-linked application for metabolic maps. Nucleic Acids Res 2011;39:W400-W405.
247. Baddely A, Turner R. spatstat: an R package for analyzing spatial point patterns. J Stat Softw 2005;12:1-42.